CC Chemokine Ligand 18 Correlates with Malignant Progression of Prostate Cancer
Guo Chen(Guangzhou First People's Hospital), Weide Zhong(Macau University of Science and Technology)
Cited by 47
Related Papers
Overexpression of BUB1B contributes to progression of prostate cancer and predicts poor outcome in patients with prostate cancer
|OncoTargets and Therapy|2016|120
E2F1 promotes tumor cell invasion and migration through regulating CD147 in prostate cancer
|International Journal of Oncology|2016|59
SOCS6 Functions as a Tumor Suppressor by Inducing Apoptosis and Inhibiting Angiogenesis in Human Prostate Cancer
|Current Cancer Drug Targets|2018|37
Enhanced expression of IMPDH2 promotes metastasis and advanced tumor progression in patients with prostate cancer
|Clinical & Translational Oncology|2014|34
Targeting FGFR1 enhances olaparib sensitivity via MAPK-mediated BRCA2 downregulation in mCRPC
|Translational Andrology and Urology|2025|0